Dylan’s bedaquline paper one of the most read in Microbial Genomics in September! Philip Fowler, 20th October 202520th October 2025 Received a lovely email from Dr Peter Cotgreave who is the Chief Executive of the Microbiological Society to say Dylan’s manuscript where he created a resistance catalogue for bedaquiline was one of the most viewed papers in Microbial Genomics during September. Never had that before, but a nice surprise! Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Related publication research tuberculosis
antimicrobial resistance Diagnosing antibiotic resistance: future trends? 23rd April 20175th August 2018 It is Sunday, I’m in Vienna at the European Congress of Clinical Microbiology and Infectious… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
antimicrobial resistance New preprint: Predicting pyrazinamide resistance by machine learning 29th April 201929th April 2019 Usually, the protein that an antibiotic binds is essential for bacterial survival, which is how… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More
New preprint: comparing different genetics analysis pipelines for tuberculosis 13th January 202513th January 2025 Ruan Spies has done a careful systematic comparison of the current genetics pipelines that purport… Share this: Share on X (Opens in new window) X Share on Bluesky (Opens in new window) Bluesky Email a link to a friend (Opens in new window) Email Share on LinkedIn (Opens in new window) LinkedIn Share on Mastodon (Opens in new window) Mastodon Read More